Atlas Trials

BE Study of the Combinations of Gemigliptin 50mg and Metformin HCl Extended Release 2000mg in Comparison to Each Component Administered Alone

Clinical trial NCT02670018 · UNKNOWN

Trial details

NCT number
NCT02670018
Sponsor
LG Life Sciences
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy
Start date
2015-08-01
Primary completion
2015-12-01
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.